With the increase of stress related illnesses in the workplace in Japan, corporate management has had to think differently. The natural disasters of March 2011 not only got Chief Executives thinking about the issues, but also illustrated the affect of employee mental health on the workplace more clearly. Although the disasters are behind us, the mental health issues are still something we must consider in any business.
For the C20 meeting, we will welcome an expert in this area, Dr. Linda Semlitz. Dr. Semlitz currently is managing the Tokyo English Life line and has recently done presentations for the American Chamber of commerce (more on Dr. Semlitz here). In the lunch discussion, she will give a short presentation followed by the traditional CEO discussion. The meeting will cover
-Implications of depression on the workplace
-Employer liablities that the CEO needs to understand
-How to recognize real stress and depression in your workplace and deal with it effectively
Date- Friday, 8 July 1230PM-1400PM
Roppongi Hills Club- Roppongi Hills Club- La Cucina Restaurant (Italian)
51 fl. Roppongi Hills Mori Tower,
6-10-1 Roppongi, Minato-ku,
Tokyo, 106-6151 Japan
Dr. Semlitz is an American trained Psychiatrist with board certification in both Child and Adolescent Psychiatry as well as General Psychiatry.
She completed her undergraduate education at Brown University in 1975 and received her medical degree from Brown University in 1978. Dr. Semlitz completed her Psychiatry training at the Cornell University, New York Hospital Westchester division and her Child and Adolescent Psychiatry training at New York State Psychiatric Institute of Columbia University.
Dr. Semlitz has practiced psychiatry for over 25 years in both the United States, Hong Kong and Singapore and has had academic appointments at Columbia University, Oregon Health Sciences University, Chinese University of Hong Kong, and National University of Singapore.
More recently she was the Medical Director of Merck, Sharpe and Dohme in Hong Kong and Director of Medical and Scientific Affairs at Banyu, a division of Merck in Japan. She has particular interest in multidisciplinary diagnosis and treatment ADHD, anxiety and depression, cross cultural mental health, and community mental health